Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: Possible morphological and biochemical alterations

Pharmacological Reports

Volumn 66, Issue 1, 2014, Pages 169-173

  Dodda, Dilip ^a,b   Chhajed, Ruchi ^c   Mishra, Jitendriya ^d,e  

^a KAKATIYA UNIVERSITY   (India)

^b Vaagdevi College of Pharmacy   (India)

^c NMT Gujarati College of Pharmacy   (India)

^d Roland Institute of Pharmaceutical Sciences   (India)

^e PANJAB UNIVERSITY   (India)

Author keywords

Acetic acid; Inflammatory bowel disease; Myeloperoxidase; Quercetin; Ulcer area

Indexed keywords

ACETIC ACID; GLUTATHIONE; MYELOPEROXIDASE; NITRATE; NITRITE; QUERCETIN; SALAZOSULFAPYRIDINE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; INFLAMMATORY BOWEL DISEASE; LIPID PEROXIDATION; MALE; MORPHOLOGY; NONHUMAN; OXIDATIVE STRESS; PREMEDICATION; RAT; ULCER HEALING; ANIMAL; BLOOD; CHEMICALLY INDUCED; COLON; DRUG EFFECTS; INFLAMMATORY BOWEL DISEASES; METABOLISM; PATHOLOGY; WISTAR RAT;

ACETIC ACID; ANIMALS; COLON; GLUTATHIONE; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; MALE; NITRITES; PEROXIDASE; QUERCETIN; RATS; RATS, WISTAR;

EID: 84899620674     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2013.08.013     Document Type: Article

References (20)

1. Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 2002;252:475-96 (Pubitemid 35454325)
2. Budarf ML, Labbé C, David G, Rioux JD. GWA studies: rewriting the story of IBD. Trends Genet 2009;25:137-46
3. Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003;56:351-61 (Pubitemid 37188129)
4. Elson CO, Sartor RB, Tennyson GS, Riddell H. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67
5. Ganguly AK. A method for quantitative assessment of experimentally produced ulcers in stomach of rats. Experientia 1969;25:1124
6. Gregory S, Kelly ND. Quercetin. Altern Med Rev 2011;16:172-94
7. Hagar HH, El-Medany A, El-Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid induced colitis in rats. Eur J Phamacol 2007;554:69-77 (Pubitemid 44822587)
8. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006;12:S3-9 (Pubitemid 43068428)
9. Hendrikson BA, Gokhle R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94 (Pubitemid 34052583)
10. Lefkowitz DL, Mills K, Morgan D, Lefkowitz SS. Macrophage activation and immunomodulation by myeloperoxidase. Proc Soc Exp Biol Med 1992;199: 204-10
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75
12. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988;263:17205-08 (Pubitemid 19029311)
13. Millar AD, Rampton DS, Chander CL, Claxson AWD, Blake DR. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease in a rat model of colitis. Gut 1996;39:407-15 (Pubitemid 26338530)
14. Miranda K, Espy MG, Wink DA. A rapid and simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71 (Pubitemid 34146173)
15. Moron MS, Depierre JW, Mannervik B. Level of glutathione, glutathione reductases and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78 (Pubitemid 9065588)
16. Mustafa A, El-Medany A, Hagar HH, El-Medany G. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol Res 2006;53: 324-30 (Pubitemid 43670506)
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8 (Pubitemid 9194347)
18. Papadakis KA, Targan SR. The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 2000;6:303-13
19. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2000;347:417-29
20. Tsianos EV, Katsanos K. Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol 2009;15:521-5.